Dr. Reddy's Laboratories is currently trading at Rs. 3084.50, down by 10.30 points or 0.33% from its previous closing of Rs. 3094.80 on the BSE.
The scrip opened at Rs. 3094.10 and has touched a high and low of Rs. 3116.00 and Rs. 3051.00 respectively. So far 13,042 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 3689.00 on 20-Jul-2016 and a 52 week low of Rs. 2814.80 on 15-Feb-2016.
Last one week high and low of the scrip stood at Rs. 3175.00 and Rs. 2945.00 respectively. The current market cap of the company is Rs. 51,099.45 crore.
The promoters holding in the company stood at 26.79%, while Institutions and Non-Institutions held 44.46% and 12.17% respectively.
The company has reported 85.15% rise in its net profit at Rs 438.80 crore for third quarter ended December 31, 2016 as compared to Rs 237.00 crore for the same quarter in the previous year. Total income of the company increased by 6.02% at Rs 2657.50 crore for the quarter under review as compared to Rs 2506.50 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported 15.95% fall in its net profit after taxes and share of profit of associates at Rs 492.30 crore for the quarter ended December 31, 2016, as compared to Rs 585.70 crore for the same quarter in the previous year. Total income of the company decreased by 6.88% at Rs 3763.50 crore for the quarter under review as compared Rs 4041.50 crore for the corresponding quarter previous year.